Compare

BPC-157 (Oral) vs SS-31

Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.

Observational reporting only — not medical advice. Does not recommend doses, protocols, or treatments.

BPC-157 (Oral)

26 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 97% · Mixed 3% · Unfavorable overall 0%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Recovery
157

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Digestive upset
4

Self-reported dose per injection

Median bucket: 0.6–1 mg · Most common: 1–2 mg

Reports span 0.2–2 mg

0.2–0.4 mg
50
0.4–0.6 mg
6
0.6–1 mg
49
1–2 mg
52

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

How repeat users are trending

Among repeat reporters, 90% said they felt similar to their last entry, 10% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 215 days · Based on 20 repeat reporters

SS-31

58 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 2% · Mixed 2% · Unfavorable overall 96%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Energy
187

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Injection site irritation
183

Self-reported dose per injection

Median bucket: 5+ mg · Most common: 5+ mg

Reports span 0.025 to ≥ 5 mg (open-ended top bucket)

0.025–0.05 mg
10
0.2–0.4 mg
2
0.4–0.6 mg
1
0.6–1 mg
4
1–2 mg
18
2–3 mg
20
3–5 mg
6
5+ mg
125

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

How repeat users are trending

Among repeat reporters, 92% said they felt similar to their last entry, 8% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 73 days · Based on 37 repeat reporters